Mr. Bernard Gloster:

It is a sizeable amount of money. Normal vaccination or immunisation programmes would be more predictable, so the backdrop is important in terms of the approximately €30 million worth that went out of date. I would make one slight addition to the Comptroller and Auditor General’s observation on the balance that was due to go out of date. My information is that they were either due to go out of date or the clinical guidance had changed in terms of the evolution of the vaccine. Maybe the chief clinical officer could explain that better than I can.